Delta 9 Cannabis Inc DLTNF

Healthcare Cannabis

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.

GREY:DLTNF - Post by User

Delta 9 Cannabis Inc > Retail!

<< Previous

Bullboard Posts

Next >>

Comment by kavern23on Mar 31, 2021 8:01pm

146 Views

Post# 32919926

RE:RE:Retail!

It's exciting man. The lack of interest in DN actually gets me even more excited.
Happy this board is quiet and lots of people are angry. Love it.

7:30 AM i will be ready

Wolf85 wrote: I've got to admit, at first I was underwhelmed. After I spent a bit more time projecting out numbers I think there is a path to a $3 valuation in 2021.

As you mention retial stores are planned to more than double in 2021 to a total of 20 (#10 & #11 already opened since year end 2020). With a doubling in stores, there is a path to being at a +100% run rate by year end 2021 (~$120M annual revenue). Cost of sales also doubles to ~$80M leaving a gross profit of ~$40M. Admin, G&A, etc also increase but not at the same rate (looks closer to +25%).

My back of the envelope projection for 2021 year end run rate is therefore;
$120M Rev - $80M COGS - $25M Expenses = $15M unadjusted earnings or ~$0.15 EPS.

At a 20X P/E it's a $3 stock. Not financial advice, anyone see it differently?